Cargando…
Serum levels of matrixmetalloproteinases MMP1 (collagenase) and MMP3 (stromelysin) before and after treatment with leflunamide in patients with rheumatoid arthritis
Autores principales: | Mangge, H, Gratze, P, Hermann, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273254/ http://dx.doi.org/10.1186/ar258 |
Ejemplares similares
-
Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease.
por: Bramhall, S. R., et al.
Publicado: (1996) -
Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer
por: Padala, Chiranjeevi, et al.
Publicado: (2017) -
Higher Content but Not Activity of Stromelysin-2 (MMP-10) in Comparison to Stromelysin-1 (MMP-3) in Human Renal Carcinoma
por: Kudelski, Jacek, et al.
Publicado: (2022) -
Inhibition of MMP1, MMP2 and MMP8 by mepacrine
por: Pollaschek, C, et al.
Publicado: (2003) -
Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers
por: Kerkelä, E, et al.
Publicado: (2001)